Wendy future of retail top

Legislation targeting REMS abuse adds to bipartisan action on solutions to Boost competition and lower Rx drug costs

PCMA applauds new legislation to boost competition and lower Rx drug costs

PCMA applauds new legislation to boost competition and lower Rx drug costs

WASHINGTON — The Pharmaceutical Care Management Association, PCMA, applauds Senators Maggie Hassan (D, N.H.) and Mike Braun (R, Ind.) for recently reintroducing legislation, the Prescription Drug Competition Act, which aims to encourage greater competition in the prescription drug market that is critical to helping lower costs. The bill targets potential abuses of Risk Evaluation and

PP_1170x120_10-25-21